2026-10-05 · CRL
CRL: shares up while sales fall
Over 3 months, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s shares moved +33%; its latest quarterly revenue was −3% vs a year earlier. A question worth asking, not a verdict.
The story in plain words
Monday, October 5, 2026. CRL: shares up while sales fall. Over 3 months, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.’s shares moved +33%; its latest quarterly revenue was −3% vs a year earlier. A question worth asking, not a verdict.
What the data shows for Charles River Laboratories (CRL): Shares +33.4% over 3 months. Latest quarterly revenue −2.7% vs a year earlier.
Possible contributors. These line up in time with the move; they are not confirmed causes: The gap may reflect expectations about future results, which this chart does not show. (Context, not a conclusion).
About the company: Charles River Laboratories trades as CRL and is part of the S&P 500, in the Health Care sector (Life Sciences Tools & Services), headquartered in Wilmington, Massachusetts, founded in 1947.
This is one of CookieStocks’ daily stock stories about S&P 500 stocks whose share price and business results have moved in different directions. Stories are found automatically each trading day from market data and SEC filings, and every claim is labelled as observed, calculated or a possible contributor. Statistics only, not investment advice.
Prove it
Every claim on the graphic, labelled: observed (straight from the data), calculated (worked out from it), or possible contributor (lines up in time, not a confirmed cause).
- OBSERVEDShares +33.4% over 3 monthsOct 5, 2026, 1:05 PM ET
- OBSERVEDLatest quarterly revenue −2.7% vs a year earlierSource: SEC EDGAR
- POSSIBLE CONTRIBUTORThe gap may reflect expectations about future results, which this chart does not show.Context, not a conclusion.
More stories
Statistics only, not investment advice. Past moves don’t predict future ones. Data as of Oct 5, 2026, 1:05 PM ET.